Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Journal of Pharmacokinetics and Pharmacodynamics|December 14, 2005
Propagation of population PK and PD information using a Bayesian approach: dealing with non-exchangeabilityAristides Dokoumetzidis, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|December 15, 2015
What do we mean by identifiability in mixed effects models?Marc Lavielle, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|December 2, 2005
Propagation of population pharmacokinetic information using a Bayesian approach: comparison with meta-analysisAristides Dokoumetzidis, Leon Aarons
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 14, 2021
Reduced physiologically-based pharmacokinetic model of dabigatran etexilate-dabigatran and its application for prediction of intestinal P-gp-mediated drug-drug interactionsJennifer Lang, Ludwig Vincent, Marylore Chenel, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 28, 2011
Translational pharmacokinetics: challenges of an emerging approach to drug development in strokeAndrew D Greenhalgh, Kayode Ogungbenro, Nancy J Rothwell, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2015
Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonistKayode Ogungbenro, Sharon Hulme, Nancy Rothwell, et al.
Clinical Pharmacology and Therapeutics|September 16, 2017
Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost AnalysisKayode Ogungbenro, Alkesh Patel, Robert Duncombe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 14, 2023
Exploring the Boundaries for In Vitro-In Vivo Extrapolation: Use of Isolated Rat Hepatocytes in Co-culture and Impact of Albumin Binding Properties in the Prediction of Clearance of Various Drug TypesLaura Francis, Kayode Ogungbenro, Tom De Bruyn, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 27, 2002
Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect dataGordon Graham, Suneel Gupta, Leon Aarons
Pageof 17